Literature DB >> 22343781

The ESHRE PGD Consortium: 10 years of data collection.

J C Harper1, L Wilton, J Traeger-Synodinos, V Goossens, C Moutou, S B SenGupta, T Pehlivan Budak, P Renwick, M De Rycke, J P M Geraedts, G Harton.   

Abstract

BACKGROUND: Since it was established in 1997, the ESHRE PGD Consortium has been collecting data from international preimplantation genetic diagnosis (PGD) centres. Ten papers have been published, including data from January 1997 to December 2007.
METHODS: The data collection originally used a hard-copy format, then an excel database and finally a FileMaker Pro database. The indications are divided into five categories: PGD for chromosome abnormalities, sexing for X-linked disease, PGD for single gene defects, preimplantation genetic screening (PGS) and PGD for social sexing. The main end-points are pregnancy outcome and follow-up of deliveries.
RESULTS: In data collection I, 16 centres contributed data, which increased to 57 centres by data X (average of 39 centres per data collection). These centres contributed data on over 27 000 cycles that reached oocyte retrieval. Of these cycles, 61% were for aneuploidy screening, 17% for single gene disorders, 16% for chromosomal abnormalities, 4% for sexing of X-linked disease and 2% for social sexing. Cumulatively, 5187 clinical pregnancies gave rise to 4140 deliveries and 5135 newborns (singletons: 3182, twins: 921, triplets: 37).
CONCLUSIONS: In this paper, we present an overview of the first 10 years of PGD data, highlighting trends. These include the introduction of laser-assisted biopsy, an increase in polar body and trophectoderm biopsy, new strategies, methodologies and technologies for diagnosis, including recently arrays, and the more frequent use of freezing biopsied embryos. The Consortium data reports represent a valuable resource for information about the practice of PGD.

Entities:  

Mesh:

Year:  2012        PMID: 22343781     DOI: 10.1093/humupd/dmr052

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  66 in total

1.  The clinical application of preimplantation genetic diagnosis for the patient affected by congenital contractural arachnodactyly and spinal and bulbar muscular atrophy.

Authors:  Linjun Chen; Zhenyu Diao; Zhipeng Xu; Jianjun Zhou; Wanjun Wang; Jie Li; Guijun Yan; Haixiang Sun
Journal:  J Assist Reprod Genet       Date:  2016-07-09       Impact factor: 3.412

2.  Evaluation of PCR-based preimplantation genetic diagnosis applied to monogenic diseases: a collaborative ESHRE PGD consortium study.

Authors:  Jos Dreesen; Aspasia Destouni; Georgia Kourlaba; Birte Degn; Wulf Christensen Mette; Filipa Carvalho; Celine Moutou; Sioban Sengupta; Seema Dhanjal; Pamela Renwick; Steven Davies; Emmanouel Kanavakis; Gary Harton; Joanne Traeger-Synodinos
Journal:  Eur J Hum Genet       Date:  2013-12-04       Impact factor: 4.246

3.  Preimplantation diagnosis for β-thalassemia combined with HLA matching: first "savior sibling" is born after embryo selection in Brazil.

Authors:  Rita C S Figueira; Amanda S Setti; Sylvia S Cortezzi; Ciro D Martinhago; Daniela P A F Braga; Assumpto Iaconelli; Edson Borges
Journal:  J Assist Reprod Genet       Date:  2012-09-27       Impact factor: 3.412

4.  Concurrent whole-genome haplotyping and copy-number profiling of single cells.

Authors:  Masoud Zamani Esteki; Eftychia Dimitriadou; Ligia Mateiu; Cindy Melotte; Niels Van der Aa; Parveen Kumar; Rakhi Das; Koen Theunis; Jiqiu Cheng; Eric Legius; Yves Moreau; Sophie Debrock; Thomas D'Hooghe; Pieter Verdyck; Martine De Rycke; Karen Sermon; Joris R Vermeesch; Thierry Voet
Journal:  Am J Hum Genet       Date:  2015-05-14       Impact factor: 11.025

5.  Birth of a healthy boy after PGD for X-linked heterotaxy syndrome.

Authors:  R Bautista-Llácer; M Pardo-Belenguer; E García-Mengual; C Sánchez-Matamoros; E Raga; J M Calafell; M S Cívico; F Fábregues; X Vendrell
Journal:  J Assist Reprod Genet       Date:  2014-05-29       Impact factor: 3.412

6.  Interchromosomal effect in carriers of translocations and inversions assessed by preimplantation genetic testing for structural rearrangements (PGT-SR).

Authors:  E Mateu-Brull; L Rodrigo; V Peinado; A Mercader; I Campos-Galindo; F Bronet; S García-Herrero; M Florensa; M Milán; C Rubio
Journal:  J Assist Reprod Genet       Date:  2019-11-06       Impact factor: 3.412

7.  Two different microarray technologies for preimplantation genetic diagnosis and screening, due to reciprocal translocation imbalances, demonstrate equivalent euploidy and clinical pregnancy rates.

Authors:  Kyle J Tobler; Paul R Brezina; Andrew T Benner; Luke Du; Xin Xu; William G Kearns
Journal:  J Assist Reprod Genet       Date:  2014-04-26       Impact factor: 3.412

8.  Pregnancy and Birth After a Two-Step PGD: Polar Body Diagnosis for Hemophilia A and Array CGH on Trophectoderm Cells for Chromosomal Aberrations.

Authors:  W Würfel; R Suttner; D Shakeshaft; V Mayer; U Schoen; K Sendelbach; M Locher; U Koehler; K Fiedler; G Krüsmann; E Holinski-Feder
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-08       Impact factor: 2.915

9.  The decision-making process, experience, and perceptions of preimplantation genetic testing (PGT) users.

Authors:  Shachar Zuckerman; Sigal Gooldin; David A Zeevi; Gheona Altarescu
Journal:  J Assist Reprod Genet       Date:  2020-05-27       Impact factor: 3.412

10.  Pre-implantation genetic testing: decisional factors to accept or decline among in vitro fertilization patients.

Authors:  Brandy Lamb; Erin Johnson; Leslie Francis; Melinda Fagan; Naomi Riches; Isabella Canada; Alena Wilson; Amber Mathiesen; Maya Sabatello; Shawn Gurtcheff; Erica Johnstone; Erin Rothwell
Journal:  J Assist Reprod Genet       Date:  2018-08-03       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.